Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - lidocaine as hydrochloride; methylprednisolone acetate - suspension for injection - lidocaine as hydrochloride 10 mg/ml; methylprednisolone acetate 40 mg/ml - methylprednisolone, combinations - lidocaine - depo-medrol with lidocaine is indicated as adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in: - synovitis of osteoarthritis - rheumatoid arthritis - acute and subacute bursitis - acute gouty arthritis - epicondylitis - acute nonspecific tenosynovitis - post-traumatic osteoarthritis.

Philippines - English - FDA (Food And Drug Administration)

pfizer, inc. - methylprednisolone - tablet - 16

United States - English - NLM (National Library of Medicine)

dispensing solutions, inc. - methylprednisolone acetate (unii: 43502p7f0p) (methylprednisolone - unii:x4w7zr7023) - methylprednisolone acetate 80 mg in 1 ml - when oral therapy is not feasible and the strength, dosage form, and route of administration of the drug reasonably lend the preparation to the treatment of the condition, the intramuscular use of depo-medrol sterile aqueous suspension is indicated as follows: allergic states: control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, seasonal or perennial allergic rhinitis, serum sickness, transfusion reactions. dermatologic diseases : bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, severe erythema multiforme (stevens-johnson syndrome). endocrine disorders: primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy, mineralocorticoid supplementation is of particular importance), congeni

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

pfizer sa-nv - methylprednisolone 32 mg - tablet - 32 mg - methylprednisolone 32 mg - methylprednisolone

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

impexeco - methylprednisolone - tablet - 32 mg - methylprednisolone 32 mg - methylprednisolone

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

pfizer sa-nv - methylprednisolone 16 mg - tablet - 16 mg - methylprednisolone 16 mg - methylprednisolone

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

impexeco - methylprednisolone - tablet - 16 mg - methylprednisolone 16 mg - methylprednisolone

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

orifarm - methylprednisolone - tablet - 16 mg - methylprednisolone 16 mg - methylprednisolone

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

orifarm - methylprednisolone - tablet - 32 mg - methylprednisolone 32 mg - methylprednisolone

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

impexeco sa-nv - methylprednisolone 32 mg - tablet - methylprednisolone